Home›Companies›Healthcare›Q'Apel Medical

Q'Apel Medical, Inc.

Updated Oct 29, 2026·Latest SEC filing May 9, 2024·Suggest an edit

About Q'Apel Medical

Q'Apel Medical is a private company based in Fremont, California. It has reported $68,927,888 raised in three offerings on Form D since February 2021. Its chief executive is R. Nelson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 26, 2024May 9, 2024$17,130,411of $42.1M target6$2.8MEquityRule 506(b)Form D ↗
Mar 31, 2022Apr 4, 2022amended May 10, 2022$29,897,481of $33.0M target7$4.2MEquityRule 506(b)Form D/A ↗1 earlier filing
Feb 5, 2021Feb 18, 2021$21,899,996of $21.9M target6$3.6MEquityRule 506(b)Form D ↗
Total, three offerings$68,927,888

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Q'Apel Medical's Form D filed May 9, 2024.

RN
R. Nelson
Chief Executive Officer and director
Scott Huennekens
Scott Huennekens
Director
Also a chairman of the board at Elucid and a director at Foldax.
CM
LK

Earlier filings also listed Scot Huennekens (director, last listed May 2022) and J. Roop (director, last listed May 2022).

Sources

  1. SECQ'Apel Medical, Inc. Form D, filed Apr 4, 2022
  2. SECQ'Apel Medical, Inc. filing history